文献速递痛风与晶体性关节病

全基因组测序在7339名中国参与者中鉴定血清尿酸的新非编码遗传变异

Identification of Novel Noncoding Genetic Variants of Serum Urate Using Whole-Genome Sequencing in 7,339 Chinese Participants.
PubMed 文献 · Arthritis Rheumatol · 2026-04-22

研究验证了常见和低频位点关联,发现MAN1A2男性特异性新位点及CPE候选位点,并鉴定HDC和SLC22A12附近罕见启动子变异的新关联。结论揭示东亚特异性等位基因结构,为精准降尿酸治疗提供转化机会。

要点

  • 鉴定出MAN1A2男性特异性新位点及CPE候选低频男性特异性位点。
  • 罕见错义和功能缺失变异聚集于SLC22A12、SLC2A9和G6PC2。
  • HDC和SLC22A12附近罕见启动子变异与血清尿酸关联。

核心结论

  • 研究解析了东亚人群血清尿酸特异性等位基因结构,揭示祖源多样性,推进精准降尿酸治疗并优先新候选基因。

主要发现

  • 验证了常见和低频位点关联,发现可重复的MAN1A2男性特异性新位点及CPE候选低频男性特异性位点。
  • 使用STAARpipeline检出SLC22A12、SLC2A9和G6PC2基因的罕见错义和推定功能缺失变异聚集,并在复制数据集或UK Biobank中验证。
  • 鉴定并复制了HDC和SLC22A12附近罕见启动子变异的新关联,提示非编码调控作用。
  • 基于深度学习的精细定位提示HNF1A、RUNX1和SRF转录因子可能是血清尿酸相关基因的上调因子。

临床怎么用

  • MAN1A2和CPE男性特异性位点提示尿酸遗传调控存在性别差异,可能用于男性高尿酸风险分层。
  • SLC22A12、SLC2A9和G6PC2罕见变异及HDC、SLC22A12启动子变异为降尿酸药物靶点提供候选。

局限性

  • 研究仅纳入汉族参与者,结果外推至其他东亚人群需谨慎。
  • 原文未报告样本量以外的统计阈值、P值或置信区间等具体数值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the genetic architecture of low-frequency and rare variants of serum urate (SU) in East Asian populations, and to clarify its role as a heritable and modifiable risk factor for gout and cardiometabolic diseases. METHODS: We conducted the largest two-stage, whole-genome sequencing-based, genome-wide scan for SU levels in East Asians, analyzing 9.1 million variants across 7,339 Han Chinese participants from the Healthy Zhejiang One Million People (HOPE) cohort. RESULTS: We verified associations at common and low-frequency loci and identified a novel, replicable male-specific locus at MAN1A2, along with a candidate low-frequency male-specific locus at CPE. Furthermore, using the STAARpipeline framework, we probed rare missense and putative loss-of-function variant aggregates in genes such as SLC22A12, SLC2A9, and G6PC2, which were validated in our replication data set or the UK Biobank. Moreover, we identified and replicated novel associations with rare promoter variants near HDC and SLC22A12, highlighting their potential role in the context of noncoding regulation. Additionally, deep learning-based fine-mapping revealed transcription factors such as HNF1A, RUNX1, and SRF as potential up-regulators of SU-associated genes. CONCLUSION: By resolving East Asian-specific allelic architecture and revealing ancestral diversity in SU genetics, this study advanced translational opportunities for precision urate-lowering therapies and prioritized novel candidates for future research.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Tan Q, Zhou H, Jia J, et al. Identification of Novel Noncoding Genetic Variants of Serum Urate Using Whole-Genome Sequencing in 7,339 Chinese Participants. Arthritis Rheumatol. 2026. PMID: 41873804. doi:10.1002/art.70150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。